Home » Topics » BioWorld Science

BioWorld Science
RSS

FDA requests additional data on H. pylori diagnostic

Dec. 4, 1996

Synsorb Pk licensed to major Japanese pharmaceutical company

Dec. 4, 1996

Alteon amends ACTION II trial

Dec. 4, 1996

Cholesterol-lowering activity reported for Yamanouchi LTD4 antagonist

Dec. 4, 1996

Chugai starts phase I clinical trials with phosphate binder

Dec. 4, 1996

Calydon's lead cancer therapeutic progresses toward clinical trials

Dec. 4, 1996

Vascular Therapeutics licenses Recordati compound

Dec. 4, 1996

Shionogi product pipeline in review

Dec. 4, 1996

BMS-Aurora research agreement on screening technology

Dec. 4, 1996

Promising clinical results reported for C. parvum therapeutic

Dec. 4, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 1, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections
BioWorld
GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...